PCR or antigen test for Covid 19 or Inluenza
Diagnostic TestPCR or antigen test for Covid 19 or Inluenza
NCT Number: NCT05087355
The overall project aim is to study outcomes after COVID-19 and influenza hospitalisation from 2016 - 2021 by retrieving data from the main social security carriers in Austria for the years 2010-2018
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PCR or antigen test for Covid 19 or Inluenza
Time frame: 5 years
Overall mortality after influenza or covid-19
Time frame: 5 years
age distribution in patients with influenza or covid-19
Time frame: 5 years
risk profile (e.g. prior diseases, medication) in patients who died due to influenza or covid-19
Time frame: 5 years
newly diagnosed diseases after influenza or covid-19
Time frame: 5 years
newly prescribed medication after influenza or covid-19
Time frame: 5 years
duration of hospitalisation or unemployability after influenza or covid-19
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07287137
COVID - 19, COVID -19
Bethesda, Maryland, United States
View Trial DetailsNCT06599658
Arthritis, Arthritis, Rheumatoid
Montreal, Quebec, Canada
View Trial DetailsNCT06817096
COVID 19, COVID-19
View Trial DetailsNCT06698549
COVID 19, COVID-19
Miami, Florida, United States
View Trial Details